Comerica Incorporated

    Comerica Incorporated

    NNYSE:CMA
    88.67
    USD
    0.00
    (0.00%)
    21.26P/E
    Comerica Incorporated
    NYSE:CMA
    (New York Stock Exchange)

    Recent

    price

    88.67

    P/E

    ratio

    21.26

    div

    yld

    - -

    ROIC.AI

    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    2025
    TTM
    USD
    14.32
    13.26
    13.52
    13.94
    14.02
    15.5
    16.5
    18.16
    19.83
    22.31
    20.87
    21.99
    26.96
    27.21
    24.46
    - -
    19.41
    Revenue per Share
    0.91
    2.13
    2.71
    2.96
    3.32
    2.96
    2.76
    4.26
    7.36
    8.02
    3.47
    8.49
    8.61
    6.5
    5.09
    - -
    4.09
    Basic EPS, GAAP
    7.02
    3.66
    3.21
    4.02
    3.18
    4.24
    2.26
    5.82
    9.09
    6.7
    6.09
    4.18
    4.24
    8.32
    3.38
    - -
    3.19
    Free Cash Flow per Basic Share
    0.42
    0.4
    0.5
    0.67
    0.77
    0.84
    0.88
    1.03
    1.57
    2.68
    2.75
    2.91
    2.87
    2.98
    3.02
    - -
    2.26
    Dividend per Share
    36.86
    36.27
    36.8
    40.86
    44.13
    46.79
    49.08
    51.75
    59.11
    71.28
    77.9
    86.24
    94.59
    97.49
    99.22
    - -
    - -
    Book Value per Share
    33.16
    33.65
    32.72
    39.17
    41.43
    39.34
    41.44
    41.97
    40.92
    44.66
    50.32
    50.91
    31.68
    45.55
    46.37
    - -
    - -
    Tangible Book Value per Share
    170
    184
    192
    183
    179
    176
    173
    174
    168
    150
    140
    135
    131
    132
    133
    130
    130
    Basic Weighted Avg Shares
    2,435
    2,445
    2,598
    2,544
    2,504
    2,724
    2,848
    3,168
    3,328
    3,343
    2,912
    2,967
    3,534
    3,592
    3,244
    - -
    2,516
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    124
    122
    133
    122
    123
    118
    121
    121
    120
    114
    108
    99
    92
    87
    96
    - -
    74
    Depreciation Expense
    277
    393
    521
    541
    593
    521
    477
    743
    1,235
    1,202
    497
    1,168
    1,151
    881
    698
    - -
    547
    Net Income, GAAP
    17.46
    25.85
    31.63
    31.17
    31.84
    30.53
    28.81
    39.79
    19.54
    21.85
    19.97
    21.61
    22.02
    22.99
    21.4
    - -
    21.41
    Effective Tax Rate (%)
    11.38
    16.07
    20.05
    21.27
    23.68
    19.13
    16.75
    23.45
    37.11
    35.96
    17.07
    39.37
    32.57
    24.53
    21.52
    - -
    21.74
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Working Capital
    6,138
    4,944
    4,720
    2,543
    2,328
    3,058
    4,812
    4,622
    5,602
    6,385
    4,823
    1,919
    2,183
    6,206
    6,673
    - -
    - -
    LT Debt
    5,793
    6,868
    6,942
    7,150
    7,402
    7,560
    7,796
    7,963
    7,507
    7,327
    8,050
    7,897
    5,181
    6,406
    6,543
    - -
    - -
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    2.5
    6.07
    7.57
    7.45
    7.73
    6.47
    5.71
    8.49
    13.03
    11.67
    4.49
    10.18
    9.39
    6.79
    5.19
    - -
    8.06
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    ST Debt
    2,925
    - -
    - -
    LT Borrowings
    5,762
    5,422
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    392
    - -
    Shares Outstanding
    130
    128
    - -
    Market Capitalization
    7,849
    8,958
    11,269

    Working Capital

    USD

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    Total Current Assets
    - -
    - -
    - -
    Cash, Cash Equivalents & STI
    12,896
    16,980
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    - -
    - -
    - -
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    2,925
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    - -
    Free Cash Flow
    - -
    - -
    - -
    Net Income, GAAP
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    990
    924
    896
    782
    3,592
    2024
    784
    824
    811
    825
    3,244
    2025
    829
    849
    838
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    2.42
    2.04
    1.86
    0.2
    6.5
    2024
    1
    1.51
    1.35
    1.24
    5.09
    2025
    1.27
    1.44
    1.37
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.71
    0.75
    0.74
    0.76
    2.98
    2024
    0.74
    0.74
    0.75
    0.79
    3.02
    2025
    0.76
    0.74
    0.75
    - -
    - -
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • seekingalpha.com

      Fifth Third: Solid Q3 Should Calm Margin Fears (Upgrade)

    • reuters.com

      Engie to build biomethane plant in France to fuel CMA CGM's fleet

    • globenewswire.com

      Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos

    • 247wallst.com

      Fifth Third Raises Dividend While Walking Capital Tightrope Post-Comerica Deal

    • globenewswire.com

      Brink's Issues Statement on CMA's Fast-Track Announcement

    • marketbeat.com

      Fifth Third Sees Q3 at High End After Comerica Conversion

    • pymnts.com

      Fifth Third Completes Comerica Integration to Become 9th Largest US Bank

    • businesswire.com

      Fifth Third Completes Comerica Technology and Brand Conversion

    • zacks.com

      Will FITB's Branch Expansion & Comerica Deal Pay Off for Investors?

    • gurufocus.com

      Dow Jones Debuts 'Dow Jones Energy' to Provide Essential Market Intelligence for a Transforming Global Landscape

    • pymnts.com

      Fifth Third Begins Comerica Account Migration After Merger

    • businesswire.com

      Fifth Third Brings Lower Fees, Early Pay and New Everyday Banking Benefits to Comerica Customers

    • reuters.com

      CMA CGM will impose emergency surcharge due to renewed Hormuz tensions

    • pymnts.com

      Fifth Third Sees Comerica Merger Wins Ahead of Labor Day Conversion

    • wsj.com

      Fifth Third Profit Boosted by Comerica Acquisition

    • seekingalpha.com

      Fifth Third Q2 Preview: Merger Benefits Already Priced In

    • wsj.com

      French Shipping Company CMA CGM to Buy FedEx Supply Chain for $1.4 Billion

    • reuters.com

      CMA CGM to buy FedEx third-party logistics arm in $1.4 billion deal

    • businesswire.com

      Canadian Marketing Association Reveals Reimagined Brand Identity, in Anticipation of the Organization's 60th Anniversary

    • gurufocus.com

      New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myel